Pregnancy in patients with advanced chronic liver disease
Silvia Degli Esposti – 26 September 2014 – Watch a video presentation of this article
Intrahepatic cholestasis of pregnancy: Diagnosis and management
Yannick Bacq, Loïc Sentilhes – 26 September 2014 – Watch a video presentation of this article
Preeclampsia‐induced Liver Dysfunction, HELLP syndrome, and acute fatty liver of pregnancy
Ghassan M. Hammoud, Jamal A. Ibdah – 26 September 2014 – Watch a video presentation of this article
Liver transplantation for portopulmonary hypertension
James R. Runo – 26 September 2014 – Watch a video presentation of this article
Viral hepatitis and pregnancy
Hellan Kwon, Anna S. Lok – 26 September 2014 – Watch a video presentation of this article
Pregnancy and the liver
Jennifer M. Ryan, Michael A. Heneghan – 26 September 2014 – Watch a video presentation of this article
Double‐negative feedback loop between MicroRNA‐422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis
Jin Zhang, Yun Yang, Tian Yang, Shengxian Yuan, Ruoyu Wang, Zeya Pan, Yuan Yang, Gang Huang, Fangming Gu, Beige Jiang, Chuan Lin, Weiping Zhou – 24 September 2014 – Growing evidence indicates that the aberrant expression of microRNAs (miRNAs) contributes to tumor development; however, the function of miRNAs in human hepatocellular carcinoma (HCC) remains largely undefined.
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
Paola Dongiovanni, Salvatore Petta, Cristina Maglio, Anna Ludovica Fracanzani, Rosaria Pipitone, Enrico Mozzi, Benedetta Maria Motta, Dorota Kaminska, Raffaela Rametta, Stefania Grimaudo, Serena Pelusi, Tiziana Montalcini, Anna Alisi, Marco Maggioni, Vesa Kärjä, Jan Borén, Pirjo Käkelä, Vito Di Marco, Chao Xing, Valerio Nobili, Bruno Dallapiccola, Antonio Craxi, Jussi Pihlajamäki, Silvia Fargion, Lars Sjöström, Lena M. Carlsson, Stefano Romeo, Luca Valenti – 24 September 2014
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
Paola Dongiovanni, Salvatore Petta, Cristina Maglio, Anna Ludovica Fracanzani, Rosaria Pipitone, Enrico Mozzi, Benedetta Maria Motta, Dorota Kaminska, Raffaela Rametta, Stefania Grimaudo, Serena Pelusi, Tiziana Montalcini, Anna Alisi, Marco Maggioni, Vesa Kärjä, Jan Borén, Pirjo Käkelä, Vito Di Marco, Chao Xing, Valerio Nobili, Bruno Dallapiccola, Antonio Craxi, Jussi Pihlajamäki, Silvia Fargion, Lars Sjöström, Lena M. Carlsson, Stefano Romeo, Luca Valenti – 24 September 2014
Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C
Tariq Ahmad, Philip Yin, Jeffrey Saffitz, Paul J. Pockros, Jacob Lalezari, Mitchell Shiffman, Bradley Freilich, Joann Zamparo, Kyle Brown, Dessislava Dimitrova, Monica Kumar, Doug Manion, Margo Heath‐Chiozzi, Robert Wolf, Eric Hughes, Andrew J. Muir, Adrian F. Hernandez – 24 September 2014 – Treatment for chronic hepatitis C virus (HCV) infection is evolving from interferon (IFN)‐based therapy to direct‐acting antiviral (DAA) agents, yet some safety concerns have arisen involving cardiac toxicity.